Literature DB >> 15984348

The emergence of Clostridium difficile as a pathogen of food animals.

J Glenn Songer1.   

Abstract

Clostridium difficile causes pseudomembranous colitis in humans, usually after disruption of the bowel flora by antibiotic therapy. Factors mediating the frank disease include the dose and toxigenicity of the colonizing strain, its ability to adhere to colonic epithelium, the concurrent presence of organisms that affect multiplication and toxin production or activity, and the susceptibility of the host. Toxins A (an enterotoxin) and B (a cytotoxin) play the major role in pathogenesis and the detection of toxins in gut contents is the gold standard for diagnosis. Disease in horses takes the form of often-fatal foal hemorrhagic enteritis. Nosocomial, antibiotic-associated, disease is increasingly common in adult horses. Enteric clinical signs are reported in ostriches, companion animals and recently calves. Clostridium difficile colitis is now a common diagnosis in neonatal pigs in the USA and elsewhere. Clinical features include onset at 1-5 days of age, sometimes with dyspnea, mild abdominal distension and scrotal edema, and commonly with yellow, pasty diarrhea. There is mesocolonic edema grossly, with microscopic diffuse colitis, mucosal edema, crypt distension, epithelial necrosis and superficial mucosal erosion. Neutrophil infiltration of the lamina propria is common, and fibrin and numerous rod-shaped bacteria are observed on the surface. About two-thirds of litters and one-third of piglets will be affected (based upon positive toxin tests), although this appears to vary with the season. The case fatality rate is probably low if considering only direct effects of C. difficile infection. The significance of toxin-positive non-diarrheic pigs and the nature of the interaction of toxins A and B with enterocytes are unknown. Given the widespread occurrence of the disease, there is substantial effort to develop immunoprophylactic products.

Entities:  

Mesh:

Year:  2004        PMID: 15984348     DOI: 10.1079/ahr200492

Source DB:  PubMed          Journal:  Anim Health Res Rev        ISSN: 1466-2523            Impact factor:   2.615


  28 in total

1.  Clinical impressions of anthrax from the 2006 outbreak in Saskatchewan.

Authors:  Chelsea G Himsworth; Connie K Argue
Journal:  Can Vet J       Date:  2009-03       Impact factor: 1.008

2.  Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digests.

Authors:  Aiqi Fang; Donald F Gerson; Arnold L Demain
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

3.  Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains.

Authors:  R A Stabler; D N Gerding; J G Songer; D Drudy; J S Brazier; H T Trinh; A A Witney; J Hinds; B W Wren
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

4.  Evaluation of four different diagnostic tests to detect Clostridium difficile in piglets.

Authors:  E C Keessen; N E M Hopman; L A M G van Leengoed; A J A M van Asten; C Hermanus; E J Kuijper; L J A Lipman
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

5.  Clostridium difficile: a new zoonotic agent?

Authors:  Alexander Indra; Heimo Lassnig; Nina Baliko; Peter Much; Anita Fiedler; Steliana Huhulescu; Franz Allerberger
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

6.  Protective efficacy induced by recombinant Clostridium difficile toxin fragments.

Authors:  Rosanna Leuzzi; Janice Spencer; Anthony Buckley; Cecilia Brettoni; Manuele Martinelli; Lorenza Tulli; Sara Marchi; Enrico Luzzi; June Irvine; Denise Candlish; Daniele Veggi; Werner Pansegrau; Luigi Fiaschi; Silvana Savino; Erwin Swennen; Osman Cakici; Ernesto Oviedo-Orta; Monica Giraldi; Barbara Baudner; Nunzia D'Urzo; Domenico Maione; Marco Soriani; Rino Rappuoli; Mariagrazia Pizza; Gillian R Douce; Maria Scarselli
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

7.  Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing.

Authors:  George Killgore; Angela Thompson; Stuart Johnson; Jon Brazier; Ed Kuijper; Jacques Pepin; Eric H Frost; Paul Savelkoul; Brad Nicholson; Renate J van den Berg; Haru Kato; Susan P Sambol; Walter Zukowski; Christopher Woods; Brandi Limbago; Dale N Gerding; L Clifford McDonald
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

8.  Clostridium difficile enteritis: an early postoperative complication in inflammatory bowel disease patients after colectomy.

Authors:  Sarah J Lundeen; Mary F Otterson; David G Binion; Emily T Carman; William J Peppard
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

9.  Development of a consensus method for culture of Clostridium difficile from meat and its use in a survey of U.S. retail meats.

Authors:  Brandi Limbago; Angela D Thompson; Sharon A Greene; Duncan MacCannell; Charles E MacGowan; Beverly Jolbitado; Henrietta D Hardin; Stephanie R Estes; J Scott Weese; J Glenn Songer; L Hannah Gould
Journal:  Food Microbiol       Date:  2012-08-21       Impact factor: 5.516

10.  Clostridium difficile in retail meat products, USA, 2007.

Authors:  J Glenn Songer; Hien T Trinh; George E Killgore; Angela D Thompson; L Clifford McDonald; Brandi M Limbago
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.